| abstract |
The compounds of formula (I) and / or their stereoisomeric forms and / or physiologically acceptable salts thereof according to the present invention provide for the preparation of medicaments for the treatment and prophylaxis of diseases involving matrix-degradable metalloproteinases during the process. Suitable forn n n Formula In n n n n n n n Matrix-degradable metalloproteinases, degenerative joint disease, connective tissue disorders, vascular disease, inflammation |